Publication | Open Access
Primary prophylaxis with mTOR inhibitor enhances T cell effector function and prevents heart transplant rejection during talimogene laherparepvec therapy of squamous cell carcinoma
10
Citations
49
References
2024
Year
| Year | Citations | |
|---|---|---|
2020 | 2.5K | |
2009 | 1.5K | |
2011 | 1.5K | |
2018 | 1.5K | |
2017 | 1.4K | |
2009 | 1.2K | |
1999 | 750 | |
2008 | 714 | |
2012 | 579 | |
2022 | 556 |
Page 1
Page 1